Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Chao

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Gastroenterology|August 9, 2005
A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis BChing-Lung Lai, Nancy Leung, Eng-Kiong Teo, et al.
Hepatology (Baltimore, Md.)|December 15, 2007
Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trialJinlin Hou, You-Kuan Yin, Daozhen Xu, et al.
The New England Journal of Medicine|December 21, 2007
Telbivudine versus lamivudine in patients with chronic hepatitis BChing-Lung Lai, Edward Gane, Yun-Fan Liaw, et al.
Nature Communications|June 10, 2025
Iterative transcription factor screening enables rapid generation of microglia-like cells from human iPSCSonglei Liu, Li Li, Fan Zhang, et al.
Microbiology Spectrum|September 15, 2021
Laboratory-Generated DNA Can Cause Anomalous Pathogen Diagnostic Test ResultsLindsey R Robinson-McCarthy, Alexander J Mijalis, Gabriel T Filsinger, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Gastroenterology|August 9, 2005
A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis BChing-Lung Lai, Nancy Leung, Eng-Kiong Teo, et al.
Hepatology (Baltimore, Md.)|December 15, 2007
Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trialJinlin Hou, You-Kuan Yin, Daozhen Xu, et al.
The New England Journal of Medicine|December 21, 2007
Telbivudine versus lamivudine in patients with chronic hepatitis BChing-Lung Lai, Edward Gane, Yun-Fan Liaw, et al.
Nature Communications|June 10, 2025
Iterative transcription factor screening enables rapid generation of microglia-like cells from human iPSCSonglei Liu, Li Li, Fan Zhang, et al.
Microbiology Spectrum|September 15, 2021
Laboratory-Generated DNA Can Cause Anomalous Pathogen Diagnostic Test ResultsLindsey R Robinson-McCarthy, Alexander J Mijalis, Gabriel T Filsinger, et al.
Pageof 2